We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > financial results

News List

Novartis delivered solid 2016 performance worldpharmanews
January 26, 2017
Novartis announced today that the net sales were USD 48.5 billion (-2%, 0% cc) in the full year, as volume growth of 6 percentage points was offset by the negative impact of generic competition (-4 percentage points) and pricing (-2 percentage points).
Abbott reports fourth-quarter 2016 results worldpharmanews
January 26, 2017
Abbott (NYSE: ABT) has announced that fourth-quarter 2016 worldwide sales of $5.3 billion increased 2.8 percent on a reported basis, including an unfavorable 1.0 percent effect of foreign exchange, and increased 3.8 percent on an operational basis.
Johnson & Johnson Reports 2016 Fourth-Quarter Results americanpharmaceuticalreview
January 25, 2017
Johnson & Johnson has announced sales of $18.1 billion for the fourth quarter of 2016, an increase of 1.7% as compared to the fourth quarter of 2015.

Previous page 1 2 3 4 5 6 Next page